Spyre Therapeutics, Inc (SYRE) has an average rating of buy and mean price target of $66.50, according to analysts polled by FactSet.
(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)
Price: $63.57, Change: $+12.28, Percent Change: +23.94%